TARA insider trading

NasdaqGM Healthcare

PROTARA THERAPEUTIC INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades
219
Last 90 days
0
Buys / sells
19% / 37%
Market cap
$276.37M

About PROTARA THERAPEUTIC INC

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Company website: www.protaratx.com

TARA insider activity at a glance

FilingIQ tracks 219 insider transactions for TARA in filings since Jan 13, 2020. The most recent transaction is dated Jun 30, 2026.

Across the full history, 42 open-market purchases and 82 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TARA insider trades is 46.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest TARA Form 4 filings

Shefferman Jesse
SGM Jul 1, 2026
Levy Richard S
A Jun 16, 2026
Solomon Michael Edward
A Jun 16, 2026
Smith Cynthia
A Jun 16, 2026
SARGEN GREGORY
A Jun 16, 2026
Huang Jane
A Jun 16, 2026
GARCEAU ROGER
A Jun 16, 2026
Flannelly Barry P
A Jun 16, 2026
BESHAR LUKE M
A Jun 16, 2026
CONKLING WILLIAM
F Jun 3, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading TARA

Frequently asked

How many insider trades does FilingIQ track for TARA?
FilingIQ tracks 219 Form 4 insider transactions for TARA (PROTARA THERAPEUTIC INC), covering filings from Jan 13, 2020 onwards. 0 of those are dated within the last 90 days.
Are TARA insiders net buyers or net sellers?
Across the full Form 4 history for TARA, 42 transactions (19%) were open-market purchases and 82 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TARA insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is TARA in?
PROTARA THERAPEUTIC INC (TARA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $276.37M.

Methodology & sources

Every TARA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.